Most articles on liver transplant eligibility follow a familiar format. They list diseases. They list scoring systems. They list medical conditions.
But in real transplant practice, indications and contraindications are not static checklists. They are dynamic clinical judgements made under uncertainty.
This article looks at liver transplant indications and contraindications from a practical decision-making perspective – how transplant teams actually think when deciding whether surgery will improve life and survival.
A Transplant Is Offered When Medicine Stops Changing The Future
The strongest indication for liver transplant is not diagnosis. It is a trajectory. Many patients live for years with cirrhosis.
What changes the discussion is when medical treatment can no longer control the direction of the disease. The decision is triggered when complications become:
- Frequent
- Progressive
- Difficult to stabilise
- Increasingly hospital-dependent
This is rarely captured by a single lab value. It is observed over repeated admissions and deteriorating recovery between episodes.
Indication Is About Biological Failure, Not Only Organ Failure
Liver transplant is indicated when liver disease begins to disrupt other organ systems. Examples include:
- Kidney function is deteriorating due to liver disease
- Repeated brain dysfunction episodes
- Refractory fluid accumulation
- Persistent low blood pressure
- Poor nutritional status
The liver is failing, but more importantly, the body is failing to compensate. This systemic impact is a stronger indicator than liver enzyme levels.
The Hidden Indication: Loss Of Physiological Reserve
One of the earliest real indicators is loss of recovery capacity. A patient who once recovered quickly from infections or procedures now:
- Takes longer to stabilise
- Requires longer hospital stays
- Develops complications after minor stress
This declining reserve predicts poor survival without a transplant. It is one of the most powerful but least documented indicators.
Indications Depend On Disease Behaviour, Not Disease Name
Two patients with the same diagnosis may have completely different transplant timings. For example:
- One may have stable disease with a good quality of life
- The other may have repeated emergency admissions
The indication is created by the behaviour of the disease, not by its label.
When Liver Cancer Becomes An Indication
Liver transplant for cancer is not based only on tumour presence. It is based on tumour biology. Teams assess:
- Number of tumours
- Size
- Response to local therapy
- Growth pattern
- Spread outside the liver
The goal is not tumour removal. The goal is long-term disease control. If the cancer shows aggressive behaviour, the transplant becomes ineffective.
So cancer is an indication only when biology is favourable.
A Difficult But Important Indication: Failure Of Quality Of Life
In advanced liver disease, some patients suffer continuously from:
- Itching
- Fatigue
- Pain
- Malnutrition
- Repeated procedures
When quality of life becomes severely compromised despite optimal medical care, transplant becomes ethically justifiable.
This is rarely written in guidelines. But it plays a role in real decisions.
Another Real Indication: Loss Of Treatment Options
When complications cannot be managed safely anymore, even if survival is still possible, a transplant is considered.
Examples include:
- Repeated fluid drainage
- Frequent bleeding episodes
- Intolerance to standard medications
- progressive kidney injury due to therapy
When medicine becomes harmful, surgery becomes the alternative.
Contraindications Are Not About Exclusion
They are about futility.
A transplant is contraindicated – when it is unlikely to improve survival or meaningful recovery. This perspective is more important than rigid criteria.
The Most Powerful Contraindication: Inability To Recover
Some patients may survive surgery. But they cannot recover functional life. Severe muscle wasting. Severe frailty. Bed-bound state. Advanced cognitive decline.
These conditions predict:
- Prolonged ventilation
- Repeated infections
- Prolonged ICU dependence
- Poor rehabilitation potential
When recovery is unlikely, a transplant becomes inappropriate.
Active Infection Is Not Always A Simple Contraindication
Uncontrolled infection is dangerous. But controlled or localised infection may not be an absolute barrier.
Teams evaluate:
- Source control
- Antibiotic response
- Stability trend
The real contraindication is an infection that cannot be controlled before surgery. Not merely the presence of infection.
Cancer Outside Transplant Boundaries
Extrahepatic spread. Vascular invasion. Rapid progression despite therapy.
These features indicate poor post-transplant survival. So cancer becomes a contraindication not because it exists, but because it will return quickly.
The Psychological And Behavioural Domain Is Decisive
One of the strongest predictors of long-term graft survival is adherence. Contraindications include:
- Ongoing substance misuse
- Untreated severe psychiatric illness
- Repeated non-compliance with medical care
- Unstable social environment
These are not moral judgements. They are outcome predictors. Without reliable adherence, graft survival falls sharply.
Another Rarely Discussed Contraindication: Lack Of Support Systems
Patients need caregivers. Transportation. Financial planning. Medication access. Monitoring support. If these systems do not exist, postoperative care becomes unsafe.
This is an operational contraindication. Not a biological one. But it affects outcomes significantly.
Age Is Not A Contraindication. Frailty Is.
Chronological age alone does not predict recovery. Biological age matters. Some older patients have strong functional reserves. Some younger patients are severely frail.
Frailty assessment is becoming central in decision-making.
Cardiac And Pulmonary Disease Are Not Black-And-White Barriers
Mild to moderate disease may be optimised. Severe irreversible disease increases perioperative mortality. The decision depends on:
- Reversibility
- Functional limitation
- Optimisation potential
The real contraindication is non-correctable physiological failure.
Kidney Disease Complicates Indications
Some patients develop kidney failure due to liver disease. Some have independent kidney disease. The distinction is critical.
If kidney injury is reversible after transplant, transplant remains indicated. If kidney disease is advanced and irreversible, a combined organ transplant may be required. If neither option is feasible, transplant may be contraindicated.
This complexity is often oversimplified.
The Most Misunderstood Contraindication: Obesity
Excess weight alone is not a strict barrier. But severe obesity is associated with:
- Poor mobility
- Diabetes complications
- Cardiovascular disease
- Wound healing risk
can increase surgical and postoperative risk. The decision depends on functional status and metabolic health, not weight alone.
A Silent Contraindication: Delayed Referral
Late referral leads to:
- Advanced infections
- Multi-organ failure
- Severe malnutrition
By the time a transplant is considered, the patient may no longer tolerate surgery.
So, the delayed evaluation itself becomes a barrier. This is a system failure, not a patient problem.
Indications And Contraindications Change Over Time
A patient may be:
- Unsuitable today
- Optimisable over months
- Suitable later
Or:
- Suitable today
- Deteriorate rapidly
- Become unsuitable later
This dynamic nature is rarely explained. Listing is not permanent eligibility. It requires continuous reassessment.
Grey Zones Dominate Transplant Decisions
Many patients do not clearly fall into “eligible” or “ineligible”. They exist in intermediate zones.
In these situations, multidisciplinary discussion becomes essential. Different specialists contribute risk perspectives. No single score can replace this judgement.
Why Checklists Fail
Guidelines provide structure. But rigid use of criteria ignores:
- Disease behaviour
- Patient motivation
- Family support
- Rehabilitation potential
Transplant is a personalised intervention even within structured programs.
The Ethical Responsibility Behind Contraindications
Saying no to a transplant is one of the hardest clinical decisions. It is not denying treatment. It is avoiding harmful treatment.
Teams must balance:
- Limited organ availability
- Surgical risk
- Long-term benefit
- Patient suffering
This ethical dimension shapes decision-making.
A Practical Way To Understand Eligibility
Instead of asking: “Do I qualify for a transplant?” A better question is: “Will a transplant meaningfully change my future health and independence?”
This frames the decision correctly.
What Families Should Understand
Eligibility is not a reward. It is not a judgment of worth. It is a medical prediction.
Sometimes the prediction changes with optimisation. Sometimes it does not. Understanding this reduces conflict and disappointment.
The Most Overlooked Indication: Readiness For Long-Term Care
A patient who is medically suitable but unwilling to commit to:
- Lifelong follow-up
- Medication discipline
- Lifestyle restrictions
may not truly benefit from a transplant. Readiness is part of the indication.
Outcomes Justify Decisions
The success of transplant programs depends on selecting patients who can:
- Survive surgery
- Recover function
- Protect the graft
- Maintain quality of life
Indications and contraindications exist to protect – both the patient and the organ.
Closing Perspective
Liver transplant surgery is not simply offered when the liver fails.
It is offered when the entire clinical picture suggests that replacing the liver will restore a stable and functional life.
In liver transplantation, the most important decision is not made in the operating room. It is made in the multidisciplinary meeting where clinicians ask a simple but difficult question: Will this operation truly change this patient’s future?
Indications and contraindications are not rules. They are reflections of that question.
